🇺🇸 FDA
Patent

US 8993627

N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

granted A61KA61K31/16A61K31/167

Quick answer

US patent 8993627 (N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress) held by SENTIENT LIFESCIENCES, INC. expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTIENT LIFESCIENCES, INC.
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/16, A61K31/167, A61K31/375, A61K9/0014